Institution: Botswana Harvard AIDS Institute Partnership
Country of work: Botswana
What is your motivation for engaging in HIV cure and remission research?
I am a physician who has been engaged in HIV care and management in a high burden resource limited setting in Botswana, Africa for more than 9 years. When I joined the public health system in Botswana in 2008 the devastation caused by the HIV/AIDS pandemic was palpable. The introduction of triple antiretroviral therapy (ARVs) has dramatically changed the landscape of HIV/AIDS care but the burden of medication and the risk of toxicities remain as challenges which affect the quality of life of patients on ARVs. Research in HIV cure and remission brings hope for the possibility of ending HIV/AIDS.
What is your current area of research?
I am the Gaborone Clinical Research Site (CRS) Leader at Botswana Harvard AIDS Partnership Institute. We have 3 NIH/DAIDS funded networks (ACTG, IMPAACT and HPTN) at our CRS, where we conduct multisite studies in HIV treatment and prevention. I am the site Principal Investigator for the IMPAACT network and a Co-Investigator for ACTG and HPTN network.